Already a member? Sign in
Everolimus is an antineoplastic agent used in the treatment of advanced renal cell cancer, after not having therapeutic response with sunitinib or sorafenib. Off label it is used as an immunosuppressant following solid organ transplant.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Transplant rejection prevention | 1 | 0 | |||||
| Pancreatic Neuroendocrine Tumor | 1 | 0 | |||||
| Kidney Transplant | 1 | 1 |
|
||||
| Heart Transplant | 1 | 1 |
|
See all 7 patients currently taking Everolimus
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Everolimus
| Itching (pruritus) | 1 | |
|---|---|---|
| Dizziness | 1 | |
| Diarrhea | 1 | |
| Rash or skin problems | 1 | |
| Persistent cough | 1 | |
| Hives (urticaria) | 1 | |
| See all 11 reported side effects ▼ | ||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 1 | ||
| Other | 1 |
Adherence
Taking treatment as prescribed
Adherence of Everolimus
Always |
2 | 100% |
|
|---|---|---|---|
Usually |
0 | 0% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Everolimus
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
0 | 0% |
|
A little |
0 | 0% |
|
Not at all |
2 | 100% |
|
Cost
Paid out of pocket
Cost of Everolimus
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
0 | 0% |
|
< $25 |
1 | 100% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 23, 2012.